Working… Menu
Trial record 26 of 42 for:    Syncope | Child

Observational Study of the Sleuth Implantable ECG Monitoring System (OBSERV-ECG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00717106
Recruitment Status : Unknown
Verified May 2009 by Transoma Medical.
Recruitment status was:  Enrolling by invitation
First Posted : July 16, 2008
Last Update Posted : May 5, 2009
Information provided by:
Transoma Medical

Brief Summary:
The purpose of this study is to obtain information on real-world device performance clinical assessments and clinical outcomes of patients receiving the Sleuth Implantable ECG Monitoring System.

Condition or disease
Syncope Presyncope Fainting Cardiac Arrhythmia

Layout table for study information
Study Type : Observational
Estimated Enrollment : 250 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study of the Sleuth Implantable ECG Monitoring System
Study Start Date : July 2008

Primary Outcome Measures :
  1. Time to diagnosis [ Time Frame: one year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
cardiology or primary care clinics

Inclusion Criteria:

  • Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
  • Patients who experience transient symptoms that may suggest a cardiac arrhythmia

Exclusion Criteria:

  • Patients that have had a myocardial infarction (MI) < 30 days prior to implant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00717106

Layout table for location information
United States, Georgia
Piedmont Hospital
Atlanta, Georgia, United States, 30309
United States, Maryland
Western Maryland Health Systems
Cumberland, Maryland, United States, 21502
United States, Michigan
Cardiology Consultants of East Michigan
Lapeer, Michigan, United States, 48446
United States, New York
St. Luke's - Roosevelt
New York, New York, United States, 10019
United States, Ohio
SUMMA-NEOCS Health Systems
Akron, Ohio, United States, 44304
United States, Pennsylvania
Main Line Health - Lankenau Hospital
Wynnewood, Pennsylvania, United States, 19096
United States, Texas
Center for Cardiac Arrhythmias
Houston, Texas, United States, 77030
United States, West Virginia
Morgantown Internal Medicine Group
Morgantown, West Virginia, United States, 26505
Sponsors and Collaborators
Transoma Medical
Layout table for investigator information
Study Director: Wim Stegink Transoma Medical

Layout table for additonal information
Responsible Party: Wim Stegink, Transoma Medical Identifier: NCT00717106     History of Changes
Other Study ID Numbers: CLP-007
First Posted: July 16, 2008    Key Record Dates
Last Update Posted: May 5, 2009
Last Verified: May 2009
Keywords provided by Transoma Medical:
ECG monitoring
cardiac arrhythmia
Additional relevant MeSH terms:
Layout table for MeSH terms
Arrhythmias, Cardiac
Consciousness Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Heart Diseases
Cardiovascular Diseases
Pathologic Processes